174 related articles for article (PubMed ID: 16714754)
21. Role of excision repair in UVB-induced depletion and recovery of human epidermal Langerhans cells.
Jimbo T; Ichihashi M; Mishima Y; Fujiwara Y
Arch Dermatol; 1992 Jan; 128(1):61-7. PubMed ID: 1739289
[TBL] [Abstract][Full Text] [Related]
22. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne syndrome.
Leadon SA; Cooper PK
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10499-503. PubMed ID: 8248136
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
24. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
25. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema.
Berg RJ; Ruven HJ; Sands AT; de Gruijl FR; Mullenders LH
J Invest Dermatol; 1998 Apr; 110(4):405-9. PubMed ID: 9540983
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide.
Murray D; Vallee-Lucic L; Rosenberg E; Andersson B
Anticancer Res; 2002; 22(1A):21-6. PubMed ID: 12017289
[TBL] [Abstract][Full Text] [Related]
27. Repair of gamma-ray-induced DNA base damage in xeroderma pigmentosum cells.
Fornace AJ; Dobson PP; Kinsella TJ
Radiat Res; 1986 Apr; 106(1):73-7. PubMed ID: 3961106
[TBL] [Abstract][Full Text] [Related]
28. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
29. A novel missense variant and multiexon deletion causing a delayed presentation of xeroderma pigmentosum, group C.
Macke EL; Morales-Rosado JA; Gupta A; Schmitz CT; Kruisselbrink T; Lanpher B; Klee EW
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843428
[TBL] [Abstract][Full Text] [Related]
30. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
32. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.
Khan SG; Oh KS; Emmert S; Imoto K; Tamura D; Digiovanna JJ; Shahlavi T; Armstrong N; Baker CC; Neuburg M; Zalewski C; Brewer C; Wiggs E; Schiffmann R; Kraemer KH
DNA Repair (Amst); 2009 Jan; 8(1):114-25. PubMed ID: 18955168
[TBL] [Abstract][Full Text] [Related]
33. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.
Khan SG; Levy HL; Legerski R; Quackenbush E; Reardon JT; Emmert S; Sancar A; Li L; Schneider TD; Cleaver JE; Kraemer KH
J Invest Dermatol; 1998 Nov; 111(5):791-6. PubMed ID: 9804340
[TBL] [Abstract][Full Text] [Related]
34. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
35. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
36. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
38. Xeroderma pigmentosum: recent clinical and photobiological aspects.
Kondo S; Fukuro S; Nishioka K; Satoh Y
J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
[TBL] [Abstract][Full Text] [Related]
39. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts.
Emmert S; Kobayashi N; Khan SG; Kraemer KH
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2151-6. PubMed ID: 10681431
[TBL] [Abstract][Full Text] [Related]
40. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
Queille S; Drougard C; Sarasin A; Daya-Grosjean L
J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
